VYOME HOLDINGS, INC. Cash and Restricted Cash
VYOME HOLDINGS, INC. (HIND) had Cash and Restricted Cash of $7.89 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.89M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.80M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.98M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.71M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $7.89M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $8.80M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $4.98M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $5.71M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $383.39K 10-Q · filed 2026-08-12 | $4.22M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $58.37K 10-Q · filed 2026-05-12 | $2.62M 10-Q · filed 2025-05-20 |
| 2024-12-31 | $101.90K 10-Q · filed 2026-08-12 | $793.00K 10-K · filed 2025-04-04 |
| 2024-09-30 | $48.87K 10-Q · filed 2025-11-14 | $843.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $149.03K 8-K · filed 2025-09-02 | $1.15M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $2.48M 10-Q · filed 2025-05-20 | |
| 2023-12-31 | $16.65K 10-K · filed 2026-03-18 | $4.56M 10-K · filed 2024-04-01 |
| 2023-09-30 | $1.55M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $4.67M 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $9.08M 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $3.96M 10-K · filed 2025-04-04 | |
| 2022-09-30 | $6.25M 10-Q · filed 2023-11-09 | $6.25M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $11.54M 10-Q · filed 2023-08-07 | |
| 2022-03-31 | $15.46M 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $22.82M 10-K · filed 2024-04-01 | |
| 2021-09-30 | $29.29M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $40.21M 10-Q · filed 2022-08-19 | |
| 2021-03-31 | $1.95M 10-Q · filed 2022-05-23 | $8.97M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $3.01M 10-K · filed 2023-04-17 | $3.90M 10-K · filed 2021-03-12 |
| 2020-09-30 | $1.91M 10-Q · filed 2021-11-12 | $5.51M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $1.58M 10-Q · filed 2021-08-16 | $6.80M 10-Q · filed 2020-07-30 |
| 2020-03-31 | $8.91M 10-Q · filed 2021-05-12 | |
| 2019-12-31 | $2.98M 10-K · filed 2022-04-08 | $14.05M 10-K · filed 2020-02-27 |
| 2019-09-30 | $19.38M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $13.51M 10-Q · filed 2020-07-30 | |
| 2019-03-31 | $24.68M 10-Q · filed 2020-06-19 | |
| 2018-12-31 | $21.19M 10-K · filed 2021-03-12 | |
| 2018-09-30 | $21.55M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $24.21M 10-Q · filed 2019-07-24 | |
| 2018-03-31 | $33.48M 10-Q · filed 2019-05-10 | |
| 2017-12-31 | $21.11M 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |